The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Jun 2017 12:11

RNS Number : 0848I
Electrocomponents PLC
14 June 2017
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Electrocomponents plc

LEI: 549300KVXDURRKVW7R37

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Silchester International Investors LLP

4. Full name of shareholder(s) (if different from 3.):iv

Silchester International Investors International Value Equity Taxable Trust

 

Silchester International Investors International Value Equity Trust

 

Silchester International Investors International Value Equity Group Trust

 

Silchester International Investors Tobacco Free International Value Equity Trust

 

The Calleva Trust

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

13th June 2017

6. Date on which issuer notified:

14th June 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 12%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0003096442

57,367,320

57,367,320

 

 

52,850,989

 

11.97%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

 

Nominal

Delta

N/A

N/A

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,850,989

11.97%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

 

Proxy Voting:

10. Name of the proxy holder:

Silchester International Investors LLP

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

Silchester International Investors LLP ("Silchester") acts as investment manager for the clients detailed in Question 4 above (our "Clients"). In acting for our Clients, Silchester are given full discretion over their investments and are empowered to vote on their behalf. However, we do not act as our Clients' custodian and therefore shares are not held in our name but in the name of each Client's custodian bank.

 

The change in Silchester's holdings was due to a series of transactions over a series of different trading days. Details of the number of shares held before the change (shown in Section A) represent the shares held by Silchester's clients as of the date of our last Notice of Substantial Shareholder's Interest (a notification of crossing below 14% of Electrocomponent's voting rights) and not as of the last trading day before which this disclosure was triggered.

 

Notification is provided based on a total voting rights figure of 441,551,793.

14. Contact name:

Timothy J. Linehan, Senior Partner

15. Contact telephone number:

0207 518 7125

   
 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGUQUQUPMGGC
Date   Source Headline
7th Mar 20173:43 pmRNSDirector Declaration
1st Mar 201712:28 pmRNSTotal Voting Rights
15th Feb 20172:48 pmRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSTrading update
1st Feb 20172:15 pmRNSHolding(s) in Company
1st Feb 201710:37 amRNSBlock listing Interim Review
31st Jan 201710:33 amRNSTotal Voting Rights
23rd Jan 201711:59 amRNSHolding(s) in Company
13th Jan 20174:01 pmRNSNotice of trading update
3rd Jan 201711:41 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDirectorate Change
9th Dec 201610:28 amRNSHolding(s) in Company
1st Dec 201611:12 amRNSTotal Voting Rights
18th Nov 20167:00 amRNS2017 Half-year Financial Results
14th Nov 201612:37 pmRNSHolding(s) in Company
31st Oct 20161:37 pmRNSTotal Voting Rights
7th Oct 20163:47 pmRNSHolding(s) in Company
4th Oct 20161:25 pmRNSHolding(s) in Company
30th Sep 201610:12 amRNSTotal Voting Rights
15th Sep 20162:48 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSTrading Statement
12th Sep 20167:00 amRNSDirectorate Change
1st Sep 201610:19 amRNSTotal Voting Rights
1st Aug 20169:42 amRNSBlock listing Interim Review
29th Jul 20162:50 pmRNSDirector/PDMR Shareholding
29th Jul 201611:35 amRNSTotal Voting Rights
22nd Jul 20169:23 amRNSDirector/PDMR Shareholding
20th Jul 201612:43 pmRNSResult of AGM
20th Jul 20167:00 amRNSDirectorate Change
20th Jul 20167:00 amRNSTrading Statement
5th Jul 201612:06 pmRNSNotice of Trading Update
30th Jun 201611:28 amRNSTotal Voting Rights
27th Jun 201611:39 amRNSDirector/PDMR Shareholding
23rd Jun 20161:04 pmRNSDirector/PDMR Shareholding
20th Jun 201610:40 amRNSDirector/PDMR Shareholding
16th Jun 20169:44 amRNSAnnual Financial Report
31st May 201610:45 amRNSTotal Voting Rights
23rd May 201610:40 amRNSHolding(s) in Company
19th May 20167:00 amRNSFinal Results
29th Apr 201610:00 amRNSTotal Voting Rights
5th Apr 20167:00 amRNSTrading Update
1st Apr 20167:00 amRNSTotal Voting Rights
31st Mar 20167:00 amRNSDirectorate Change
29th Mar 201611:34 amRNSHolding(s) in Company
18th Mar 201612:03 pmRNSDirector/PDMR Shareholding
18th Mar 20169:53 amRNSNotice of trading update
14th Mar 201611:37 amRNSDirector/PDMR Shareholding
1st Mar 20169:22 amRNSTotal Voting Rights
10th Feb 20167:00 amRNSTrading Statement
1st Feb 201610:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.